Insiders / Maraganore John

Maraganore John

CIK 1180432personinsider

Companies

5

First seen

Mar 18, 2026

Last activity

Jun 25, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Hemab Therapeutics Holdings, Inc. · COAG	Director	35,948	107,338	5	—
Beam Therapeutics Inc. · BEAM	Director	—	19,676	1	—
Kymera Therapeutics, Inc. · KYMR	Director	—	6,068	1	—
Rapport Therapeutics, Inc. · RAPP	Director	—	15,200	1	—
Takeda Pharmaceutical Co Ltd · TAK	Director	—	—	0	—

All securities held

5 positions · latest reported per filing

Company	Security	Shares	As of
Beam Therapeutics Inc.	Stock Option (Right to Buy)Derivative	19,676	Jun 3, 2026
Hemab Therapeutics Holdings, Inc.	Common Stock	35,948	May 4, 2026
Hemab Therapeutics Holdings, Inc.	Warrants (Right to Buy)Derivative	107,338	Jan 29, 2026
Kymera Therapeutics, Inc.	Stock Option (Right to Buy)Derivative	6,068	Jun 24, 2026
Rapport Therapeutics, Inc.	Stock Option (Right to Buy)Derivative	15,200	Jun 10, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jun 24, 2026	Grant	KYMR Kymera Therapeutics, Inc. Stock Option (Right to Buy)	—	+6K	6,068 <0.01% of shares	low
Jun 10, 2026	Grant	RAPP Rapport Therapeutics, Inc. Stock Option (Right to Buy)	—	+15K	15,200 0.03% of shares	low
Jun 3, 2026	Grant	BEAM Beam Therapeutics Inc. Stock Option (Right to Buy)	—	+20K	19,676 0.02% of shares	low
May 4, 2026	Other	COAG Hemab Therapeutics Holdings, Inc. Series C Preferred Stock	—	-817 -100.00%	0 0.00% of shares	low
May 4, 2026	Other	COAG Hemab Therapeutics Holdings, Inc. Series B Preferred Stock	—	-817 -100.00%	0 0.00% of shares	low
Jan 29, 2026	Grant	COAG Hemab Therapeutics Holdings, Inc. Warrants (Right to Buy)	—	+107K	107,338 0.23% of shares	low
May 4, 2026	Other	COAG Hemab Therapeutics Holdings, Inc. Common Stock	—	+18K +100.00%	35,948 0.08% of shares	low
May 4, 2026	Other	COAG Hemab Therapeutics Holdings, Inc. Common Stock	—	+18K	17,974 0.04% of shares	low